Estrogen Receptors (ERs) are a group of proteins found inside cells and exist in two classes: ERα and ERβ. ERs are activated by estrogen and are able to translocate into the nucleus and bind to DNA to regulate the activity of different genes, but also have functions independent of DNA binding. ERs are expressed in >70% of all breast cancers with ERα being the main target in clinical approaches for controlling hormonally responsible breast cancer. ERα is associated with a variety of other cancers, including prostate, liver, and pancreatic ductal adenocarcinoma.

The AlphaLISA SureFire Ultra Human Phospho-ERα (Ser167) Detection Kit is a sandwich immunoassay for the quantitative detection of phospho-ERα (Ser167) in cellular lysates, using Alpha Technology.

Formats:

• The HV (high volume) kit contains reagents to run 100 wells in 96-well format, using a 60 μL reaction volume.
• The 500-point kit contains enough reagents to run 500 wells in 384-well format, using a 20 μL reaction volume.
• The 10,000-point kit contains enough reagents to run 10,000 wells in 384-well format, using a 20 μL reaction volume.
• The 50,000-point kit contains enough reagents to run 50,000 wells in 384-well format, using a 20 μL reaction volume.

AlphaLISA SureFire Ultra kits are compatible with:

• Cell and tissue lysates
• Antibody modulators
• Biotherapeutic antibodies

Alpha SureFire kits can be used for:

• Cellular kinase assays
• Receptor activation studies
• Screening